A newly identified novel coronavirus (2019-nCoV) has caused numerous acute respiratory syndrome cases in Wuhan China from December 2019 to Feb 2020. Its fast spreading to other provinces in China and overseas is very likely causing a pandemic. Since the novel coronavirus has been reported to be capable of endangering thousands of lives, it is extremely important to find out how the coronavirus is transmitted in human organs. Apart from fever and respiratory complications, gastrointestinal symptoms are observed in some patients with 2019-nCoV but the significance remains undetermined. The cell receptor angiotensin covering enzyme II (ACE2), which is the major receptor of SARS-nCoV, has been reported to be a cellular entry receptor of 2019-nCoV as well. Here, to more precisely explore the potential pathogen transmission route of the 2019-nCoV infections in the gastrointestinal tract, we analyzed the ACE2 RNA expression profile in the colon (which was not peer-reviewed) The copyright holder for this preprint .
tissue of healthy adults and colorectal cancer patients of our cohort and other databases. The data indicates that ACE2 is mainly expressed in epithelial cells of the colon. The expression of ACE2 is gradually increased from healthy control, adenoma to colorectal cancer patients in our cohort as well as in the external Asian datasets.
According to the expression profile of ACE2 in colon epithelial cells, we speculate adenoma and colorectal cancer patients are more likely to be infected with 2019-nCoV than healthy people. Our data may provide a theoretical basis for the classification and management of future 2019-nCoV susceptibility people in clinical application.
Introduction
As one member of the family coronaviride, coronavirus are enveloped with non-segmented positive sense RNA, which are broadly distributed in humans and other mammals(1). Most of the coronavirus are harmless to human, except the beta coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) (2, 3) and
Middle East respiratory syndrome coronavirus (MERS-CoV) (4, 5) , which lead to numerous lethal respiratory disease cases in the past two decades. In December 2019, a series of unidentified pneumonia disease outbreaks was reported in Wuhan, Hubei province, China. In a subsequent pathogen identification process, 2019-nCoV (2019 novel coronavirus) was identified from the bronchoalveolar lavage fluid of these pneumonia disease patients (6, 7) . This virus was identified as the cause of the deadly pneumonia disease in human (7) . As of Feb 11, 2020, China has reported more than 42747 confirmed and more than 21675 suspected cases of 2019-nCoV infections across 33 Chinese provinces or municipalities, with 1017 fatalities. In addition, since 2019-nCoV is a novel coronavirus for human, there is no specifically effective drug for the infected patients.
Recently, Huang et al. reported that one diarrhea case was found in 38 patients with 2019-nCoV infections(8). In addition, some patients with diarrhea were constantly diagnosed in subsequent newly discovered 2019-nCoV infected cases, which indicate that 2019-nCoV may infect people via digestive systems. Although other groups have shown ACE2 expression profile in digestive system and lung by single-cell transcriptomes bioinformatics analysis from external datasets(9, 10)， unfortunately, most data of these datasets are not from Asian adults. Therefore, to provide more implications of viral transmission in clinical diagnosis and treatment, it's urgent to explore ACE2 expression in the digestive system of Asian people.
Results
To investigate the ACE2 expression pattern in the gastrointestinal tract of Asian adult samples, we incorporated two public single cell RNA-seq data of colorectal cancer (CRC) cohorts from GEO (GSE97693 and GSE81861) and one cohort from Renji Hospital. We performed single cell analysis on 504 cells from GSE97693, including 485 cell from CRC (primary tumor) and 19 cells from healthy normal control (NC). We observed that ACE2 is expressed in 38.5%(194/504) of all human colon cells. We also observed that the ACE2 expressed cells were significantly enriched in tumors when compared with healthy normal tissues (39.6% vs 10.5%, p <0.05) ( Fig. 1 A- 
Consistently, in GSE81861 dataset, ACE2 is expressed in 10.5%(62/590) of all human colon cells. We also observed that the ACE2 expressed cells were significantly enriched in colorectal tumors when compared with healthy normal tissues (12.5% vs 7.0%, p < 0.05) ( Fig.1D-F were collected after single cell RNA-seq quality control ( Fig.2A) . The ACE2 expressed cells were significantly enriched in CRC samples compared with CRA and NC samples (5.15% vs 2.94% and 1.75%, p<0.05) ( Fig.2 B, C) . In consistent with previous studies(9, 10), we also observed that ACE2 cell were mainly expressed in epithelial cells which highly express EPCAM (Fig.2D ).
Methods

Single cell sequencing
Single cell libraries were generated using the Chromium Single Cell 3′ library and gel bead kit v3 from 10x Genomics. Libraries were sequenced on the NovaSeq 6000 System (Illumina) at Shanghai GeneGenery BioTech Co.Ltd with 150 bp paired-end sequencing of reads. Gene counts were obtained by aligning reads to the hg38 angiotensin converting enzyme II (ACE2), which was known as cell receptor for SARS-CoV (6) . In addition, 2019-nCoV is able to enter lots of mammal cells with ACE2 receptor expression, but not cells without ACE2 (6) . Interestingly, 2019n-CoV just specifically uses ACE2 to infect mammal cells, but not other coronavirus receptor (6) . Therefore ACE2 receptor may be the key component for 2019-nCoV to infect human and transmit in the host body.
It is reported that ACE2 is highly expressed in the lung and other digestive tract organs in public external databases(9, 10, 18). However, Asian adult data is rare in these datasets. Here, we firstly proved that ACE2 is expressed in the colon epithelial cells of Chinese adults. Furthermore, ACE2 expression is gradually increased from normal colon epithelium, adenoma to colorectal cancer patients' tissues. Based on the expression of ACE2, colorectal cancer and adenoma patients are more likely to be infected and injured by 2019-nCoV, than healthy people.
As an angiotensin-converting enzyme (ACE) homologue (19, 20) , ACE2 is a zinc metallopeptidase that catalyzes the conversion of angiotensin I (Ang I) and
angiotensin II (Ang II) to angiotensin (1-9) and angiotensin (1-7), respectively (21) .In addition to being a functional receptor for SARS-virus to enter mammal cells, ACE2 contributes substantially to the efficiency of SARS-CoV replication as well (22) .
Recently, 2019-nCoV was confirmed to share the same cell entry receptor, ACE2, as SARS-CoV (6) . In addition, J. Byrnes et al. found that inhibition of ACE2 with GL1001, which is a selective inhibitor of this enzyme significantly reduced DSS-induced distal colon pathology, indicating that ACE2 may mediate the mucosal inflammation in DSS-induced inflammatory bowl disease (IBD) of mouse (23) . Inhibition of ACE2 may increase the level of its substrates, such as gherlin and further block the production of pro-inflammatory cytokines (24) . In a recent clinical report, 2019-nCoV may cause cytokine storm and multi-organ failure in severe pneumonia patients(8). Therefore, we speculates that 2019-nCoV may interact with ACE2 receptor in gastrointestinal tract, then further impair the intestinal mucous membrane barrier and increase the inflammatory cytokines production. With the intensification infection of 2019-nCoV, more inflammatory factors are produced, which eventually leads to a storm of inflammatory factors. Therefore, it is possible to use ACE2 inhibitors to treat 2019-nCoV patients by blocking ACE2 receptor of the intestinal epithelial cells in future clinical application.
In a word, our data support the intestinal tropism of the 2019-nCoV has some implications on clinical presentation and viral transmission. ACE2 expression is much higher in epithelia cells of colorectal cancer tissues than health control, which indicates that 2019-nCoV may be more harmful to colorectal cancer patients than 
